Atai: Following the path that Spravato laid and moving beyond it
Investing Experts
Innovating Psychedelic Therapies for Mental Health
This chapter explores a biotech company's innovative approaches to developing psychedelic therapies for treatment-resistant depression. It highlights the mission to enhance patient experience and reduce treatment frequency, while also examining the market potential following the success of existing treatments like Spravato.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
